# DESCRIPTION

## FIELD OF THE INVENTION

- define field of invention

## BACKGROUND OF THE INVENTION

- discuss limitations of conventional local anesthetics
- motivate need for prolonged nerve blockade

## SUMMARY OF THE INVENTION

- introduce anesthetic-polymer conjugates
- describe benefits of conjugates

## DETAILED DESCRIPTION OF THE INVENTION

### I. Definitions

- define terms

### II. Compositions

- introduce anesthetic-polymer conjugates
- describe anesthetic agents
- detail site 1 sodium channel blockers
- discuss vanilloid receptor subtype 1 agonists
- define capsaicin
- describe properties of capsaicin
- discuss capsaicinoids and capsinoids
- introduce polymers for controlled release
- describe poly(glycerol sebacate) (PGS)
- discuss polymers for tunable hydrophilicity
- introduce poly(ethylene glycol) (PEG)
- describe properties and uses of PEG
- define PEG compositions
- describe covalent linker moieties
- introduce spacers
- discuss penetration enhancing excipients
- formulate syringe-injectable formulations
- formulate anesthetic conjugates
- describe viscoelastic properties
- outline conjugate composition
- discuss anesthetic release rates
- describe additional active agents
- outline formulation excipients
- describe dosage forms

### III. Methods of Use

- provide nerve blockade methods
- describe anesthetic agent release
- detail methods for treating pain
- outline combination therapy
- describe dosages for pain relief
- discuss formulations for prolonged anesthesia
- outline pain conditions to be treated
- describe surgical procedures for pain prevention

### IV. Formulations and Methods of Making

- describe synthesis of TDP polymers
- outline methods for making covalent polymer-anesthetic conjugates

## EXAMPLES

### Example 1: Conjugates of Anesthetic with Amphiphilic Polymers and PEG

- describe synthesis of TDP polymers
- describe synthesis of TDP-drug conjugates
- describe characterization methods (contact angle, 1H NMR, FTIR, molecular weight measurement)
- describe in vitro degradation and cell culture studies
- describe cell viability, equilibrium solubility, and drug release studies
- describe experimental methods
- perform rheological test
- conduct animal studies
- perform confocal imaging
- perform IVIS imaging
- harvest and analyze tissue samples
- synthesize and characterize TDP polymers and TDP-TTX conjugates

### Example 2: TTX-PGS/PEG Provides Long-Duration In Vitro Drug Release without Cytotoxicity

- investigate TTX release kinetics
- determine effect of fphil on TTX release rate

### Example 3: Fabrication of Syringe-Injectable Formulation

- prepare homogeneous TDP-TTX/PEG200 formulation

### Example 4: TDP-TTX Conjugates Induce Sciatic Nerve Blockade In Vivo

- investigate effect of TTX dose on nerve blockade
- compare nerve block duration with free TTX and TDP-TTX conjugates
- examine CPE-like effect of PEG200 on TTX flux into nerve

### Example 5: fphil Effects Toxicity and Efficacy of Conjugated TTX

- investigate effect of fphil on toxicity and efficacy of conjugated TTX

### Example 7: TDP-TTX Conjugates do not Illicit a Tissue Reaction

- evaluate tissue reaction to TDP-TTX conjugates

### Example 8: PGS-PEG-TTX Conjugates Provide a Universal Therapeutic Drug Platform for all Alcoholic or Carboxylic Acid Drugs

- demonstrate universal therapeutic drug platform for all alcoholic or carboxylic acid drugs

## SUMMARY

- synthesize TDP polymers
- conjugate TTX with TDP polymers

